Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CURES: Sugammadex and Deep Neuromuscular Blockade in Gastric Bypass
NCT01748643Phase 4Completed
- Sponsor
- Ziekenhuis Oost-Limburg
- Start
- Apr 2013
- Primary completion
- Jan 2015
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Sugammadex in neuromuscular blockade (NMB), sponsored by Ziekenhuis Oost-Limburg. Started Apr 2013; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT01748643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01748643.